Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $15.69 USD
Change Today -0.10 / -0.63%
Volume 1.2M
HALO On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James P. Shaffer

Former Chief Commercial Officer, Halozyme Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

47$1,168,379
As of Fiscal Year 2014

Background*

Mr. James P. Shaffer, also known as Jim, served as Chief Commercial Officer and Vice President of Halozyme Therapeutics, Inc. until March 31, 2014. Mr. Shaffer joined Halozyme in 2011 with over 23 years of Commercial Operations experience. He has experience in both large and small pharmaceutical companies in the areas of Neurology, Psychiatry, Oncology, GI and Pulmonary Care with specialized experience in developing and marketing genetic tests in Oncology and Cardiology. ...

Read Full Background

Corporate Headquarters*

11388 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-794-8889
Fax: 858-704-8311

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
The Ohio State University
MBA
The Ohio State University

Other Affiliations*

Annual Compensation*

Salary$137,151
Total Annual Compensation$137,151

Stock Options*

Restricted Stock Awards$412,650
All Other Compensation$210,618
Exercised Options161,457
Exercised Options Value$159,807
Total Value of Options$159,807
Total Number of Options161,457

Total Compensation*

Total Annual Cash Compensation$347,769
Total Short Term Compensation$137,151
Other Long Term Compensation$623,268
Total Calculated Compensation$1,168,379
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $15.69 USD -0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
$1.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.